Thymidine phosphorylase has been used in a study to evaluate biomarkers for advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.Thymidine phosphorylase has also been used in a study to investigate implications for the clinical efficacy of nucleoside analogues.